Promotion code : C9+12
Best choice of recombinant protein for SARS-CoV-2 research!
Recombinant SARS-CoV-2 proteins are essential starting materials to support the studies in the biology of the virus and to be applied as controls during testing newly developed diagnostics and vaccines. These proteins can be challenging and time-consuming to produce, especially under the new restricted working conditions. Last year upon the outbreak of COVD-19, CROYEZ quickly developed and launched a comprehensive series of coronavirus nucleocapsid proteins which helps the researcher to distinqunsh the cross-reactivities among developed diagnostics.
Catching up with the mutants
Genetic variants of SARS-CoV-2 have been emerging and circulating around the world, raising worries that they may draw out the pandemic or make vaccines less effective.
The total solution for reliable SARS-COVID-2 research